R&D Tax Incentive
Cynata received $1,391,000 to be invested towards advancing Cynata’s robust and substantial clinical product pipeline including ongoing trials in osteoarthritis and COVID-19.
Cynata received $1,391,000 to be invested towards advancing Cynata’s robust and substantial clinical product pipeline including ongoing trials in osteoarthritis and COVID-19.
Environmental game changers lead the way amongst Entrepreneurs’ Programme grant recipients.
Funding is available to help Victorian and Israeli organisations work together on projects of mutual benefit.
ResApp Health received $93,994 aside from the R&D tax incentive refund of $707,744, for the launching of SleepCheck for sleep apnoea sufferers and the development of ResAppDx-EU.
Funding is available to support research, representation, or education projects that address issues for communications consumers in Australia. Applications now open and close 25 February 2021.
Funding is available to support multicultural community groups to undertake upgrades to community facilities.
A program to help reduce importing costs for Australian manufacturers of eligible goods.
Funding is available to promote new and innovative medical devices/technologies within NSW that may have a global benefit.. Round 9 now open and closes 1 March 2021.
Can you help provide insight into the Entrepreneurs' Programme. Take the survey now.
Funding is available to help researchers & businesses generate products & services that would benefit the economy. Applications close 17 December 2020.